Patent · US Active

Unsaturated nitrogen heterocyclic compounds useful as PDE10 inhibitors

US9718803B2 · kind B2 · utility

5Cited by
4References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 17, 2015
Grant dateAug 1, 2017
Priority date
Expiry dateDec 17, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D513/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Unsaturated nitrogen heterocyclic compounds of formula (I):as defined in the specification, compositions containing them, and processes for preparing such compounds. Provided herein also are methods of treating disorders or diseases treatable by inhibition of PDE10, such as obesity, Huntington's Disease, non-insulin dependent diabetes, schizophrenia, bipolar disorder, obsessive-compulsive disorder, and the like.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.